hunter syndrome - Robuta Search

https://www.fda.gov/news-events/press-announcements/fda-approves-drug-treat-neurologic-manifestations-hunter-syndrome FDA Approves Drug to Treat Neurologic Manifestations of Hunter Syndrome | FDA The U.S. Food and Drug Administration approved Avlayah (tividenofusp alfa-eknm) to treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type... fda approves hunter syndrome drug treat neurologic https://dnapodcast.com/episodes/2025/12/19/372-fighting-for-time-hunter-syndrome-gene-therapy-amp-urgent-advocacy #372 Fighting for Time: Hunter Syndrome, Gene Therapy & Urgent Advocacy — DNA Today Dec 19, 2025 - Kristin McKay, Executive Director of Project Alive, is dedicated to accelerating treatments, expanding care, and supporting families affected by Hunter... time hunter gene therapy 372 fighting syndrome https://www.businesstoday.in/impact-feature/story/rethinking-rare-diseases-the-silent-challenge-of-hunter-syndrome-mps-ii-521566-2026-03-20 Rethinking rare diseases: The silent challenge of hunter syndrome (MPS II) - BusinessToday Mar 24, 2026 - The symptoms are usually seen between 18 and 36 months of age, although there is a wide range of presentation, which is often classified in severe and... rare diseases silent challenge hunter syndrome rethinking mps https://www.biospace.com/drug-development/denalis-hunter-syndrome-candidate-in-the-spotlight-after-regenxbio-rejection Denali’s Hunter Syndrome Candidate in the Spotlight After REGENXBIO Rejection - BioSpace Mar 16, 2026 - The Hunter syndrome space suffered a setback in February when the FDA turned down REGENXBIO's investigational gene therapy, raising urgent questions about... hunter syndrome candidate spotlight regenxbio rejection